Skip to content
- Sweeping review suggests effect of weight-loss drugs on 175 conditions The Washington Post
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Diabetes and Obesity Drugs Study Points to Effectiveness in Curbing Addictions Bloomberg
- How GLP-1 drugs like Ozempic and Wegovy affect risk of 175 conditions New Scientist
- Weight-loss drugs reduce risk of Alzheimer’s, large study shows Financial Times